Scopia Management, Inc.
CIK 1665995 · last filed 2019-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$343.84M
Companies
2
Total Filings
32
Lifetime Open-Market Net
-$123.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ITRI | 10%+ Owner | 4,096,766 | $83.93 | $343.84M | -$23.19M | 20 | 2019-05-07 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | 10%+ Owner | 39,585 | $0.66 | $26.2K | -$100.57M | 12 | 2019-02-01 |
Recent Filings · Page 2 of 4
32 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-21 | ITRI | Sell (S) | −166,948 | -$8.41M | EDGAR |
| 2019-03-19 | ITRI | Sell (S) | −176,772 | -$8.76M | EDGAR |
| 2019-03-15 | ITRI | Sell (S) | −107,464 | -$5.37M | EDGAR |
| 2019-02-01 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −28,000 | -$448.2K | EDGAR |
| 2019-01-17 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −373,400 | -$6.32M | EDGAR |
| 2019-01-15 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −161,568 | -$2.81M | EDGAR |
| 2019-01-09 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −536,696 | -$8.81M | EDGAR |
| 2019-01-07 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −220,828 | -$3.59M | EDGAR |
| 2019-01-02 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −211,564 | -$3.17M | EDGAR |
| 2018-12-28 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −400,000 | -$5.86M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.